These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2119370

  • 1. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.
    Kikuchi Y, Iwano I, Miyauchi M, Kita T, Sugita M, Tenjin Y, Nagata I.
    Jpn J Cancer Res; 1990; 81(6-7):701-6. PubMed ID: 2119370
    [Abstract] [Full Text] [Related]

  • 2. [Establishment of a cisplatin-resistant human ovarian cancer cell line and the mechanism of resistance].
    Kikuchi Y, Iwano I, Miyauchi M, Kita T, Kizawa I, Oomori K, Kato K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):379-83. PubMed ID: 3361190
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of acquired resistance to cisplatin by a human ovarian cancer cell line.
    Kikuchi Y, Iwano I, Miyauchi M, Kita T, Oomori K, Kizawa I, Sugita M, Tenjin Y.
    Jpn J Cancer Res; 1988 May; 79(5):632-5. PubMed ID: 3136116
    [Abstract] [Full Text] [Related]

  • 4. Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
    Kikuchi Y, Iwano I, Miyauchi M, Sasa H, Nagata I, Kuki E.
    Gynecol Oncol; 1990 Nov; 39(2):199-203. PubMed ID: 2227596
    [Abstract] [Full Text] [Related]

  • 5. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
    Hirata J, Kikuchi Y, Kita T, Imaizumi E, Tode T, Ishii K, Kudoh K, Nagata I.
    Int J Cancer; 1993 Sep 30; 55(3):521-7. PubMed ID: 8375936
    [Abstract] [Full Text] [Related]

  • 6. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M.
    Biomed Pharmacother; 2009 Sep 30; 63(8):553-60. PubMed ID: 18571892
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
    Kudoh K, Kikuchi Y, Hiramatsu H, Hirata J, Yamamoto K, Kita T, Nagata I.
    Eur J Cancer; 1997 Jan 30; 33(1):122-8. PubMed ID: 9071911
    [Abstract] [Full Text] [Related]

  • 8. cis-Diamminedichloroplatinum-resistant cell lines derived from human epithelial ovarian carcinoma express increased susceptibility to angiogenesis inhibitor TNP-470.
    Tamura M, Takakuwa K, Tanaka K.
    Gynecol Oncol; 2004 Feb 30; 92(2):530-6. PubMed ID: 14766244
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells.
    Kikuchi Y, Hirata J, Kita T, Imaizumi E, Tode T, Nagata I.
    Gynecol Oncol; 1993 Jun 30; 49(3):365-72. PubMed ID: 8314539
    [Abstract] [Full Text] [Related]

  • 10. Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells.
    Kamazawa S, Kigawa J, Minagawa Y, Itamochi H, Shimada M, Takahashi M, Sato S, Akeshima R, Terakawa N.
    Oncology; 2000 Nov 30; 59(4):329-35. PubMed ID: 11096346
    [Abstract] [Full Text] [Related]

  • 11. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.
    Kikuchi Y, Hirata J, Yamamoto K, Ishii K, Kita T, Kudoh K, Tode T, Nagata I, Taniguchi K, Kuwano M.
    Jpn J Cancer Res; 1997 Feb 30; 88(2):213-7. PubMed ID: 9119751
    [Abstract] [Full Text] [Related]

  • 12. [Reduced cisplatin-uptake by cisplatin-resistant human ovarian cancer cells].
    Kikuchi Y, Iwano I, Miyauchi M.
    Gan To Kagaku Ryoho; 1988 Oct 30; 15(10):2895-8. PubMed ID: 3178239
    [Abstract] [Full Text] [Related]

  • 13. Establishment of a cisplatin-resistant human ovarian cancer cell line.
    Kikuchi Y, Miyauchi M, Kizawa I, Oomori K, Kato K.
    J Natl Cancer Inst; 1986 Dec 30; 77(6):1181-5. PubMed ID: 3467111
    [Abstract] [Full Text] [Related]

  • 14. Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.
    Misawa T, Kikkawa F, Oguchi H, Morikawa Y, Kawai M, Maeda O, Iwata M, Kano T, Furuhashi Y, Tomada Y.
    Oncology; 1992 Dec 30; 49(3):173-9. PubMed ID: 1495742
    [Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
    Misawa T, Kikkawa F, Maeda O, Obata NH, Higashide K, Suganuma N, Tomoda Y.
    Jpn J Cancer Res; 1995 Jan 30; 86(1):88-94. PubMed ID: 7737915
    [Abstract] [Full Text] [Related]

  • 16. Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II).
    Kikuchi Y, Hirata J, Hisano A, Tode T, Kita T, Nagata I.
    Gynecol Oncol; 1995 Jul 30; 58(1):11-5. PubMed ID: 7789875
    [Abstract] [Full Text] [Related]

  • 17. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, Uegaki K, Naniwa J, Sato S, Shimada M, Oishi T, Terakawa N, Kigawa J, Harada T.
    Int J Gynecol Cancer; 2012 Jul 30; 22(6):922-9. PubMed ID: 22672985
    [Abstract] [Full Text] [Related]

  • 18. [Cancer chemo-endocrine therapy and its cell biological basis].
    Nishiya I.
    Hum Cell; 1998 Sep 30; 11(3):109-14. PubMed ID: 10086273
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
    Brooks SE, Korbut TT, Dupuis NP, Holden SA, Teicher BA.
    Cancer Chemother Pharmacol; 1995 Sep 30; 36(5):431-8. PubMed ID: 7634385
    [Abstract] [Full Text] [Related]

  • 20. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.
    Hiramatsu H, Kikuchi Y, Kudoh K, Kita T, Tode T, Nagata I.
    Jpn J Cancer Res; 1997 Oct 30; 88(10):1003-8. PubMed ID: 9414663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.